Colgate-Palmolive Company $CL Shares Purchased by Nvwm LLC

Posted by Francis Steltz on Oct 15th, 2026

Nvwm LLC boosted its position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 982.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,680 shares of the company’s stock after purchasing an additional 7,878 shares during the period. Nvwm LLC’s holdings in Colgate-Palmolive were worth $741,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Ashurst Perkins Coie Trust Co raised its position in Colgate-Palmolive by 3,677.5% in the 3rd quarter. Ashurst Perkins Coie Trust Co now owns 19,983 shares of the company’s stock valued at $1,705,000 after buying an additional 19,454 shares during the last quarter. ZWJ Investment Counsel Inc. boosted its position in Colgate-Palmolive by 3,335.2% during the 3rd quarter. ZWJ Investment Counsel Inc. now owns 97,904 shares of the company’s stock worth $8,353,000 after acquiring an additional 95,054 shares during the last quarter. Mather Group LLC. boosted its position in Colgate-Palmolive by 112.5% during the 3rd quarter. Mather Group LLC. now owns 26,990 shares of the company’s stock worth $2,303,000 after acquiring an additional 14,287 shares during the last quarter. Hudock Inc. boosted its position in Colgate-Palmolive by 166.4% during the 3rd quarter. Hudock Inc. now owns 7,051 shares of the company’s stock worth $602,000 after acquiring an additional 4,404 shares during the last quarter. Finally, First Pacific Financial grew its stake in shares of Colgate-Palmolive by 660.3% during the 3rd quarter. First Pacific Financial now owns 3,558 shares of the company’s stock worth $304,000 after acquiring an additional 3,090 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity

In other news, COO Panagiotis Tsourapas sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer directly owned 64,901 shares of the company’s stock, valued at $5,974,137.05. This trade represents a 13.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Noel Wallace sold 161,021 shares of the company’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the transaction, the chief executive officer owned 362,231 shares in the company, valued at approximately $33,296,273.52. This represents a 30.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 175,191 shares of company stock valued at $16,110,903 over the last three months. Insiders own 0.43% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL opened at $92.80 on Thursday. The company’s fifty day simple moving average is $89.04 and its 200 day simple moving average is $88.93. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a market cap of $73.98 billion, a price-to-earnings ratio of 36.83, a PEG ratio of 4.30 and a beta of 0.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82.

Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.36 billion for the quarter, compared to analysts’ expectations of $5.36 billion. During the same period in the prior year, the firm earned $0.92 EPS. Colgate-Palmolive’s quarterly revenue was up 4.9% compared to the same quarter last year. On average, research analysts forecast that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be paid a $0.53 dividend. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is currently 84.13%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating for the company in a research report on Monday, October 5th. BNP Paribas Exane lowered their price target on shares of Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating on the stock in a research note on Monday, September 28th. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating on the stock in a research report on Monday, August 3rd. Finally, Barclays increased their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Thirteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $98.11.

Check Out Our Latest Stock Report on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.